BioCentury
ARTICLE | Company News

Galen, Pfizer deal

March 10, 2003 8:00 AM UTC

GAL will acquire Estrostep and Loestrin oral contraceptives and a femhrt hormone replacement therapy from PFE for an upfront cash payment of $359 million. The femhrt product is from Pharmacia Corp. ...